I think that in the IP sector, for soybeans there's a very high standard of quality assurance, care, and segregation throughout the system. We're very confident of the high quality of non-GMO purity in our food grade exports. I think the markets we serve appreciate that, which is why we do well in those markets.
I think the LLP issue generally, with regard to large volumes of commodity trade, is an important element for our future. It's because there are so many more biotechnology-assisted crops and there is more volume of that trade internationally that the risk, the potential to have a very small amount of a product that is not approved in a country but is already approved using a Codex-based science process somewhere internationally, is growing all the time.
Canada can have a challenge here, because we're so export-oriented. You can have a very small presence of a crop with a GM trait unintentionally there that can disrupt the whole trade environment. Canada has experienced this with the flax trade. This is the reason that internationally there's a discussion about how to put in place low-level presence regulations.